Martin Čerňan

580 total citations
7 papers, 20 citations indexed

About

Martin Čerňan is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Martin Čerňan has authored 7 papers receiving a total of 20 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Martin Čerňan's work include COVID-19 Clinical Research Studies (3 papers), Acute Myeloid Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). Martin Čerňan is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Acute Myeloid Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). Martin Čerňan collaborates with scholars based in Czechia, Austria and Slovakia. Martin Čerňan's co-authors include Tomáš Szotkowski, Tomáš Papajík, Milan Kolář, Wolfgang R. Sperr, Tomáš Fürst, Aleš Obr, Barbora Weinbergerová, Karel Indrák, Jiří Mayer and Pavel Žák and has published in prestigious journals such as British Journal of Haematology, Annals of Hematology and Life.

In The Last Decade

Martin Čerňan

7 papers receiving 20 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Čerňan Czechia	3	9	7	7	5	4	7	20
Yetty Movieta Nency Indonesia	4	11 1.2×	6 0.9×	5 0.7×	9 1.8×	4 1.0×	13	39
Rebecca Gonzalez United States	4	5 0.6×	7 1.0×	11 1.6×	4 0.8×	5 1.3×	9	32
Ben Butler-Cole United Kingdom	3	4 0.4×	6 0.9×	3 0.4×	3 0.6×	8 2.0×	5	35
Yohan Desbrosses France	5	13 1.4×	5 0.7×	20 2.9×	7 1.4×	15 3.8×	8	43
Anupa Kudva United States	4	11 1.2×	2 0.3×	12 1.7×	10 2.0×	4 1.0×	6	34
Katlyn Lederer United States	2	4 0.4×	5 0.7×	3 0.4×	2 0.4×	6 1.5×	2	42
Anne Daguenel France	4	8 0.9×	10 1.4×	13 1.9×	2 0.4×	13 3.3×	4	43
Lia Phillips United States	3	9 1.0×	11 1.6×	12 1.7×	3 0.6×	1 0.3×	4	24
Dale Chappell United States	4	13 1.4×	15 2.1×	5 0.7×		5 1.3×	11	34
Henrike Ritterbusch Germany	3	3 0.3×	3 0.4×	8 1.1×	2 0.4×	2 0.5×	4	40

Countries citing papers authored by Martin Čerňan

Since Specialization

Citations

This map shows the geographic impact of Martin Čerňan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Čerňan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Čerňan more than expected).

Fields of papers citing papers by Martin Čerňan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Čerňan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Čerňan. The network helps show where Martin Čerňan may publish in the future.

Co-authorship network of co-authors of Martin Čerňan

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Čerňan. A scholar is included among the top collaborators of Martin Čerňan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Čerňan. Martin Čerňan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Weinbergerová, Barbora, Jiří Mayer, Wolfgang R. Sperr, et al.. (2024). Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British Journal of Haematology. 205(5). 1746–1750. 2 indexed citations

2.

Jindra, Pavel, Jan Vydra, Martin Čerňan, et al.. (2023). Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study. Annals of Hematology. 103(3). 981–992. 2 indexed citations

3.

Čerňan, Martin, Tomáš Szotkowski, Milan Kolář, et al.. (2022). Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site. Biomedical Papers. 167(3). 236–245. 1 indexed citations

4.

Čerňan, Martin, Tomáš Szotkowski, Jiří Minařík, et al.. (2022). Breakthrough COVID-19 in Vaccinated Patients with Haematologic Malignancies—The First Single-Centre Experience from the Czech Republic. Life. 12(8). 1184–1184. 1 indexed citations

5.

Čerňan, Martin, Tomáš Szotkowski, Aleš Obr, et al.. (2021). COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic. Clinical Lymphoma Myeloma & Leukemia. 21(9). 606–612. 3 indexed citations

6.

Čerňan, Martin, Tomáš Szotkowski, Petr Cetkovský, et al.. (2020). Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. 67(3). 650–659. 3 indexed citations

7.

Čerňan, Martin, et al.. (2017). Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment. Biomedical Papers. 161(3). 234–241. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact